Cargando…

The Ongoing Quest for Predictive Biomarkers in Chronic Obstructive Pulmonary Disease

Detalles Bibliográficos
Autores principales:	Regard, Lucile, Roche, Nicolas, Burgel, Pierre-Régis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2023
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492241/ https://www.ncbi.nlm.nih.gov/pubmed/37478331 http://dx.doi.org/10.1164/rccm.202306-0957ED

Ejemplares similares

Mucus Plugs in Medium-sized Airways: A Novel Imaging Biomarker for Phenotyping Chronic Obstructive Pulmonary Disease
por: Chassagnon, Guillaume, et al.
Publicado: (2021)

Chronic obstructive pulmonary disease and the COVID-19 pandemic: Reciprocal challenges
por: Deslée, G., et al.
Publicado: (2020)

Change in Lung Function after Initiation of Elexacaftor–Tezacaftor–Ivacaftor: Do Not Forget Anatomy!
por: Martin, Clémence, et al.
Publicado: (2022)

Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease
por: Perez, Thierry, et al.
Publicado: (2015)

Ongoing quest for a better predictor of difficult airway
por: Garg, Rakesh
Publicado: (2018)

Two Distinct Chronic Obstructive Pulmonary Disease (COPD) Phenotypes Are Associated with High Risk of Mortality
por: Burgel, Pierre-Régis, et al.
Publicado: (2012)

Reply to Polverino: Deconvoluting Chronic Obstructive Pulmonary Disease: Are B Cells the Frontrunners?
por: Ladjemi, Maha Zohra, et al.
Publicado: (2019)

CFTR Modulators in People with Cystic Fibrosis: Real-World Evidence in France
por: Regard, Lucile, et al.
Publicado: (2022)

Crossing Kingdoms: Host–Microbial Endotyping and the Quest to Understand Treatable Traits in Chronic Obstructive Pulmonary Disease
por: Segal, Leopoldo N., et al.
Publicado: (2021)

TAS-102 and the quest for predictive biomarkers
por: van der Velden, Daphne L, et al.
Publicado: (2017)

Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease
por: Burgel, Pierre-Régis, et al.
Publicado: (2017)

A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir
por: Joumaa, H., et al.
Publicado: (2020)

Major Decrease in Lung Transplantation for Patients with Cystic Fibrosis in France
por: Martin, Clémence, et al.
Publicado: (2021)

Transcriptome-based Signatures: The Future Biomarkers in Obstructive Pulmonary Diseases Such as Asthma and Chronic Obstructive Pulmonary Disease?
por: van den Berge, Maarten, et al.
Publicado: (2021)

The Chemical Synthesis of Tetrodoxin: An Ongoing Quest
por: Chau, Jaclyn, et al.
Publicado: (2011)

The Ongoing Quest for the Holy Bone Graft Grail: Scientific Progress, Economic Bonanza, or Quixotic Quagmire?
por: Chapman, Jens R., et al.
Publicado: (2017)

Vitamin D and Chronic Obstructive Pulmonary Disease: Biomarker Related to Outcomes
por: Park, So-Young, et al.
Publicado: (2019)

The Quest for Relevant Hepatocellular Carcinoma Biomarkers
por: Kim, Jin U., et al.
Publicado: (2017)

COVID-19 after 18 months: Where do we stand?
por: Chassagnon, Guillaume, et al.
Publicado: (2021)

Could the Sputum Microbiota Be a Biomarker That Predicts Mortality after Acute Exacerbations of Chronic Obstructive Pulmonary Disease?
por: Tsay, Jun-Chieh J., et al.
Publicado: (2019)

The quest for a biomarker of circulating osteoclast precursors
por: Ritchlin, Christopher
Publicado: (2009)

Inhaled Dual Phosphodiesterase 3/4 Inhibitors for the Treatment of Patients with COPD: A Short Review
por: Martin, Clémence, et al.
Publicado: (2021)

Leveraging Omics to Predict Chronic Obstructive Pulmonary Disease Exacerbations: The “Immunome”
por: Polverino, Francesca, et al.
Publicado: (2023)

Allergy and Chronic Obstructive Pulmonary Disease
por: Jin, Jian-Min, et al.
Publicado: (2017)

Insulin‐like growth factor binding protein‐4: The quest for the breakthrough biomarker in pulmonary arterial hypertension
por: Estrada, Rodolfo A., et al.
Publicado: (2023)

“Can’t Stop the Feeling”: Symptoms as the Key to Trial Success in Bronchiectasis?
por: Burgel, Pierre-Régis, et al.
Publicado: (2020)

Identification of Clinical Phenotypes Using Cluster Analyses in COPD Patients with Multiple Comorbidities
por: Burgel, Pierre-Régis, et al.
Publicado: (2014)

Using Health Administrative Data to Predict Chronic Obstructive Pulmonary Disease Exacerbations
por: Jiang, Lili, et al.
Publicado: (2020)

THE ONGOING QUEST FOR SUB-TYPING SUBSTANCE ABUSE : CURRENT STATUS
por: Gupta, Nitin, et al.
Publicado: (1999)

Smoking cessation and chronic obstructive pulmonary disease
por: Yoo, Kwang Ha
Publicado: (2015)

Metabolic syndrome and chronic obstructive pulmonary disease
por: Koul, Parvaiz A
Publicado: (2016)

Diaphragmatic dysfunction in chronic obstructive pulmonary disease
por: Sharma, Bharat Bhushan, et al.
Publicado: (2019)

Macrolides for treatment of chronic obstructive pulmonary disease
por: Sun, Xue-Jiao, et al.
Publicado: (2019)

The Complex Beginnings of Chronic Obstructive Pulmonary Disease
por: Guerra, Stefano, et al.
Publicado: (2020)

Chronic Obstructive Pulmonary Disease: The Present and Future
por: Krishnan, Aditya, et al.
Publicado: (2022)

The role of biomarkers in community-acquired pneumonia: predicting mortality and response to adjunctive therapy
por: Mira, Jean-Paul, et al.
Publicado: (2008)

Addressing the Use of the CAPTURE (a Chronic Obstructive Pulmonary Disease Screening Tool) in Chronic Obstructive Pulmonary Disease Treatment Decisions
por: Yawn, Barbara P., et al.
Publicado: (2023)

The metabolomic quest for a biomarker in chronic kidney disease
por: Davies, Robert
Publicado: (2018)

Systemic White Blood Cell Count as a Biomarker for Chronic Obstructive Pulmonary Disease: Utility and Limitations
por: Kim, Tae-Hyung
Publicado: (2017)

Predicting Pneumonia in Chronic Obstructive Pulmonary Disease. Have We Unraveled the Network of Risks?
por: Dransfield, Mark T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uhl7srjv8bl2vpmorjsa5i6k0o